{Reference Type}: Journal Article
{Title}: Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome.
{Author}: Fertig R;Shapiro J;Bergfeld W;Tosti A;
{Journal}: Skin Appendage Disord
{Volume}: 2
{Issue}: 3
{Year}: Jan 2017
暂无{DOI}: 10.1159/000450617
{Abstract}: Postfinasteride syndrome (PFS) is a term recently coined to characterize a constellation of reported undesirable side effects described in postmarketing reports and small uncontrolled studies that developed during or after stopping finasteride treatment, and persisted after drug discontinuation. Symptoms included decreased libido, erectile dysfunction, sexual anhedonia, decreased sperm count, gynecomastia, skin changes, cognitive impairment, fatigue, anxiety, depression, and suicidal ideation. The aim of this study is to review the existing medical literature for evidence-based research of permanent sexual dysfunction and mood changes during treatment with 5-alpha-reductase inhibitors including finasteride and dutasteride.